Structure-activity relationships for methylphenidate analogs and comparisons to cocaine and tropanes

Medicinal Chemistry Research

Volumn 8, Issue 1-2, 1998, Pages 91-99

  Deutsch, Howard M ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE; METHYLPHENIDATE; TROPANE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DOPAMINE UPTAKE; DRUG DISCRIMINATION; DRUG PROTEIN BINDING; DRUG SYNTHESIS; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0031805509     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rouse, B.A. Trends in cocaine use in the general population. Subst. Use Misuse 1997, 32, 1721-1726.
2. Ritz, M.C.; Lamb, R.J.; Goldberg, S.R.; Kuhar, M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237, 1219-1223.
3. Bergman J.; Madras, B.K.; Johnson, S.E.; Spealman, R.D. Effects of cocaine and related drugs in nonhuman primates. III. Self administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 1989, 219, 150-155.
4. Kuhar, M.J.; Ritz, M.C.; Boja, J.W. The dopamine hypothesis of the reinforcing properties of cocaine Trends Neurosci. 1991, 14, 299-302.
5. a). Safer, D.J.; Zito, J.M.; Fine, E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996, 98, 1084-1088.
6. b). Diller, L.; Morrow, R. The case of the missing methylphenidate. Pediatrics 1997, 100, 730-730.
7. c). Safer, D.J.; Zito, J.M.; Fine, E.M. The case of the missing methylphenidate - Reply. Pediatrics 1997, 100, 730-731.
8. a). Volkow, N.D.; Ding, Y.-S.; Fowler, J.S.; Wang, G.-J.; Logan, J.; Gatley, S.J.; Dewey, S.; Ashby, C.; Liebermann, J.; Hitzemann, R.; Wolf, A.P. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 1995, 52, 456-463.
9. b). Volkow, N.D.; Wang, G.J.; Gatley, S.J.; Fowler, J.S.; Ding, Y.-S.; Logan, J.; Hitzemann, R.; Angrist, B.; Lieberman, J. Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology 1996, 123, 26-33.
10. c). Volkow, N.D.; Wang, G.J.; Fowler, J.S.; Gatley, S.J.; Ding, Y.S.; Logan, J.; Dewey, S.L.; Hitzemann, R.; Lieberman, J. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy. Proc. Natl. Acad. Sci. USA 1996, 93, 10388-10392.
11. 2 receptors. Am. J. Psychiatry 1997, 154, 50-55.
12. 3H] Threo-(±)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: Correlation with the stimulant properties of ritalinic acid esters. J. Neurochem. 1985, 45, 1062.
13. Deutsch, H.M.; Schweri, M.M.; Culbertson, CT.; Zalkow, L.H. Synthesis and pharmacology of irreversible affinity labels as potential cocaine antagonists: aryl 1,4-dialkylpiperazines related to GBR-12783. Eur. J. Pharmacol., 1992, 220, 173-180.
14. Panizzon, L. The preparation of pyridines- and piperidine-arylacetonitriles and the alkylation products of transformations (Part I). Helv. Chim. Acta 1944, 27, 1748-1756.
15. Meier, R.; Gross, F.; Tripod, J. Ritalin, a new synthetic compound with specific central nervous system activity. Klin. Wochenschr. 1954, 32, 445-450.
16. a. Shafi'ee, A.; Marathe, S.; Bhatkar, R.; Hite, G. Absolute Configurations of the Enantiomeric Pheniramines, Methylphenidates, and Pipradrols. J. Pharmaceut. Sci. 1968, 57, 1689-1690.
17. b. Shafi'ee, A.; Hite, G. The Absolute Configurations of the Pheniramines, Methyl Phenidates, and Pipradols. J. Med. Chem. 1969, 12, 266-270.
18. Froimowitz, M.; Patrick, K.S.; Cody, V. Conformational analysis of methylphenidate and its structural relationship to other dopamine reuptake blockers such as CFT. Pharm. Res. 1995, 12, 1430-1434.
19. Portoghese, P.S.; Malspeis, L. Relative Hydrolytic Rates of Certain Alkyl (b) dl-α-(2-Piperidyl)-phenylacetates. J. Pharmaceut. Sci. 1961, 50, 494-501
20. 14C: Studies in Man and Animals. J. Pharmacol. Exp. Ther. 1974, 191, 535-547.
21. a). Deutsch, H.M.; Shi, Q.; Gruszecka-Kowalik, E.; Schweri, M.M. Synthesis and pharmacology of potential cocaine antagonists .2. Structure-activity relationship studies of aromatic ring- substituted methylphenidate analogs. J. Med. Chem. 1996, 39, 1201-1209.
22. b). Froimowitz, M.; Deutsch, H.M.; Shi, Q.; Wu, K.M.; Glaser, R.; Adin, I.; George, C.; Schweri, M.M. Further evidence for a dopamine reuptake pharmacophore. The effect of N-methylation on threo-methylphenidate and its analogs. Bioorg. Med. Chem. Lett. 1997, 7, 1213-1218.
23. Glaser, R; Adinà, I.; Shiftan, D.; Shi, Q.; Deutsch, H.M.; George, C.; Wu, K.-M.; Froimowitz, M. Solution and Solid-State Conformational and Structural Analysis of the N-Methyl Derivatives of (±)-77-Threo-Methylphenidate, (±)-Erythro-Methylphenidate and (±)-Threo-p-methyl-methylphenidate HCl Salts. J. Org. Chem. 1998, 63, 1785-1794.
24. a). Pan, D.; Galley, S.J.; Dewey, S.L.; Chen, R.; Alexoff, D.A.; Ding, Y.-S.; Fowler, J.S. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Eur. J. Pharmacol. 1994, 264, 177-182.
25. b). Galley, S.J.; Meehan, S.M.; Chen, R.; Pan, D.F.; Schlechter, M.D.; Dewey, S.L. Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci. 1996, 58, PL345-PL352.
26. Gatley, S.J.; Pan, D.F.; Chen, R.Y.; Chaturvedi, G.; Ding, Y.-S. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci. 1996, 58, PL231-PL239.
27. McMillen, B.A. CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmcol. 1983, 4, 429-432.
28. 3H]dopamine uptake. Eur. J. Pharmcol. 1985,705,187-191.
29. Grabowski, J.; Roache, J.D.; Schmitz, J.M.; Rhoades, H.; Creson, D.; Korszun, A. Replacement medication for cocaine dependence: Methylphenidate. J. Clin. Psychopharmacol. 1997, 17, 485-488.
30. Gawin, F.; Riodan, C.; Kleber, H. Methylphenidatae treatment of cocaine abusers without attention deficit disorder: a negative report. Am. J. Alcohol Abuse, 1985,11, 193-197.
31. For the general method see: Woolfolk, D.R.; Holtzman, S.G. The effects of opioid receptor antagonism on the discriminative stimulus effects of cocaine and d-amphetamine in the rat. Behav. Pharmacol. 1996, 7, 779-787. A detailed report of the work reported here will reported in the immediate future.
32. Boja, J.W.; Kuhar, M.J.; Kopajtic, T.; Yang, E.; Abraham, P.; Lewin, A.H.; Carroll, F.I. Secondary amine analogues of 3b-(4′-substituted phenyl)tropane- 2b-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine. J. Med. Chem. 1994, 37, 1220-1223.
33. Abraham, P.; Pitner, J.B.; Lewin, A.H.; Boja, J.W.; Kuhar, M.J.; Carroll, F.I. N-Modified analogues of cocaine: Synthesis and inhibition of binding to the cocaine receptor. J. Med. Chem. 1992, 35, 141-144.
34. Carroll, F.I.; Kotian, P.; Dehghani, A.; Gray, J.L.; Kuzemko, M.A.; Parham, K.A.; Abraham, P.; Lewin, A.H.; Boja, J.W.; Kuhar, M.J. Cocaine and 3b-(4′-substituted phenyl)tropane-2b-carboxylic acid ester and amide analogues. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 1995, 38, 379-388.
35. Slusher, B. S.; Tiffany, C. W.; Olkowski, J. L.; Jackson, P. F. Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists. Drug Alcohol Depend. 1997, 48, 43-50.